Evidence map›Paper›PMID 32976855›Full record

ArticleMetabolism: clinical and experimental2020

Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stone.

Shiva Ganjali, Vanessa Bianconi, Peter E Penson, Matteo Pirro, Maciej Banach, Gerald F Watts, Amirhossein Sahebkar

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Metabolism: clinical and experimental, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. The Association Between the Use of Statins and Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-analysis.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2022
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Distinct Features of Vascular Diseases in COVID-19.Journal of inflammation research · 2023
    Review
  10. Article
  11. COVID-19 and the heart.World journal of clinical cases · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shiva GanjaliDepartment of Medical Biotechnology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Vanessa BianconiUnit of Internal Medicine, Department of Medicine, University of Perugia, Perugia, Italy.
Peter E PensonSchool of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK.
Matteo PirroUnit of Internal Medicine, Department of Medicine, University of Perugia, Perugia, Italy.
Maciej BanachDepartment of Hypertension, Medical University of Lodz, Poland; Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland.
Gerald F WattsCardiometabolic Service, Department of Cardiology, Royal Perth Hospital, School of Medicine, University of Western Australia, Perth, Western Australia, Australia.
Amirhossein SahebkarBiotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: sahebkara@mums.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19 Drug TreatmentCardiovascular DiseasesCholesterolCoronary Artery DiseaseCOVID-19HumansHydroxymethylglutaryl-CoA Reductase InhibitorsInflammationLipid MetabolismMyeloid Differentiation Factor 88NF-kappa BPandemicsRisk FactorsSARS-CoV-2Signal TransductionVirus InternalizationCholesterolHydroxymethylglutaryl-CoA Reductase InhibitorsMYD88 protein, humanMyeloid Differentiation Factor 88NF-kappa B

Identifiers

PMID32976855
PMCPMC7511211

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.